Table 2.
MRSA prevalence in studies that estimate prevalence by Oxacillin disc compared with PCR or Cefoxitin disc compared with PCR
| Included studies(n) | Total number of MRSA | MRSA detection methods | Pooled resistance % | 95% CI | Heterogeneity | |||
|---|---|---|---|---|---|---|---|---|
| I2% (inconsistency) | Cochran Q | P value | ||||||
| studies that co-report MRSA prevalence by CDD and PCR | 15 | 1509 | PCR | 67 | [54–79] | 98.32 | 834.27 | < 0.01 |
| CDD | 67 | [55–80] | 98.19 | 774.73 | < 0.01 | |||
| studies that co-report MRSA prevalence by ODD and PCR | 9 | 868 | PCR | 60 | [45–75] | 95.92 | 195.88 | < 0.01 |
| ODD | 64 | [43–84] | 98.76 | 647.39 | < 0.01 | |||
Abbreviation: MRSA methicillin-resistant staphylococcus aureus, CDD cefoxitin disc diffusion, ODD Oxacillin disc diffusion